23andMe and Nightingale Health Partner to Offer Blood-Based Risk Assessment Pilot
What You Should Know:
– 23andMe Holding Co., a leading player in preventative health and therapeutics, and Nightingale Health, a pioneer in biomarker testing, announced a collaboration to pilot Nightingale’s blood metabolomics panel with a…
Continue Reading